Diclofenac sodium (DCS), a non-steroidal anti-inflammatory drug used for posttraumatic pain and rheumatoid arthritis, has bitter taste. Thus formulating orally dissolving tablet containing taste-masked microspheres of diclofenac sodium is extremely advantageous and challenge.